Feasibility of gabapentin as an intervention for neurorecovery after an acute spinal cord injury: Protocol

IntroductionThis protocol is describing the first ever prospective, mock-efficacy, dose exploration trial design testing the feasibility of administering gabapentin in the acute setting as an intervention for neurorecovery. Gabapentin is an FDA-approved medication for treating seizures and postherpe...

Full description

Bibliographic Details
Main Authors: James R. Wilson, Samuel Doty, Jordan C. Petitt, Mohamed El-Abtah, John J. Francis, Megan G. Sharpe, Michael L. Kelly, Kim D. Anderson
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.1033386/full